A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus ; volume:39 ; number:7 ; day:31 ; month:5 ; year:2022 ; pages:3088-3103 ; date:7.2022
Advances in therapy ; 39, Heft 7 (31.5.2022), 3088-3103, 7.2022
- Creator
-
Askanase, Anca D.
Furie, Richard A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-022-02160-y
- URN
-
urn:nbn:de:101:1-2022082009543757057129
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Askanase, Anca D.
- Furie, Richard A.
- SpringerLink (Online service)
Other Objects (12)
Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Correction to: Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus
Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis: A Narrative Review
Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus
Repository corticotropin for Chronic Pulmonary Sarcoidosis
Efficacy and tolerability of subcutaneous repository corticotropin injection in refractory ocular inflammatory diseases
Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial
Systemischer Lupus erythematosus
Cutaneous lupus erythematosus
Systemischer Lupus erythematosus
Systemic lupus erythematosus
Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Correction to: Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus
Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis: A Narrative Review
Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus
Repository corticotropin for Chronic Pulmonary Sarcoidosis
Efficacy and tolerability of subcutaneous repository corticotropin injection in refractory ocular inflammatory diseases
Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial
Systemischer Lupus erythematosus
Cutaneous lupus erythematosus
Systemischer Lupus erythematosus
Systemic lupus erythematosus
Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Correction to: Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus
Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis: A Narrative Review
Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus
Repository corticotropin for Chronic Pulmonary Sarcoidosis
Efficacy and tolerability of subcutaneous repository corticotropin injection in refractory ocular inflammatory diseases
Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial
Systemischer Lupus erythematosus
Cutaneous lupus erythematosus
Systemischer Lupus erythematosus